文献速递前列腺癌

前列腺癌男性共享决策项目启动后的实施结局评估

Evaluation of Implementation Outcomes After Initiation of a Shared Decision-making Program for Men With Prostate Cancer.
PubMed 文献 · Urology · 2019-07-09

研究评估电子病历(EMR)中患者决策辅助工具(PDA)的实施障碍,关注合格男性中实际接受PDA的比例(渗透率)及接受者中按预期使用的比例(保真度)。2013至2017年在加州大学洛杉矶分校(UCLA)招募新发局限性前列腺癌男性,PDA保真度为84%(314/374),前瞻性算法渗透率为100%(2/2),但回顾性图表审查渗透率为20%(2/10),PDA完成与更少决策冲突和更高感知共享决策相关(所有P<.03)。

要点

  • PDA保真度为84%(314/374名新发前列腺癌男性完成PDA)。
  • 前瞻性算法渗透率为100%(2/2),回顾性图表审查渗透率为20%(2/10)。
  • PDA完成与更少决策冲突和更高感知共享决策相关(所有P<.03)。

核心结论

  • 此前无研究探讨由EMR促进的PDA实施挑战,本研究识别了限制项目渗透率的可修改系统及EMR相关因素。
  • 本研究的PDA显示出决策质量获益。

研究设计与样本

  • 从UCLA招募2013至2017年新发局限性前列腺癌男性,通过每周EMR审查确定PDA资格。
  • 对某一周样本所有门诊患者进行回顾性图表审查,以识别初始资格算法遗漏的患者并调查误分类原因。
  • 分析接受与未接受PDA患者之间以患者为中心结局的差异。

主要发现

  • 314/374名新发前列腺癌男性完成了PDA,保真度为84%。
  • 初始前瞻性识别算法下PDA渗透率为100%(n=2/n=2)。
  • 手动回顾性图表审查评估的渗透率为20%(n=2/n=10)。
  • PDA完成与更少决策冲突和更高感知共享决策相关(所有P<.03)。
  • 识别出包括新EMR就诊类型在内的识别算法改进措施。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate barriers to implementation of patient decision aids (PDAs) issued in an electronic medical record (EMR). We undertook an implementation outcomes analysis focused on what proportion of men eligible for the PDA received it (penetration), and of the men who received it, how many used it as intended (fidelity). We also evaluated various patient-centered outcomes related to decision-making. MATERIALS AND METHODS: Men with incident localized prostate cancer were recruited from at UCLA from 2013 to 2017. PDA eligibility was determined via weekly EMR review. We also performed a retrospective chart review of all patients seen in clinic for one sample week to identify patients that were missed by the initial eligibility algorithm, and investigated the cause for miscategorization. We analyzed differences in patient-centered outcomes between those who did and did not receive the PDA. RESULTS: About 314/374 men with incident prostate cancer completed the PDA conferring 84% fidelity. PDA penetration under initial identification prospective algorithm was assessed at 100% (n = 2/n = 2). However, penetration assessed by manual retrospective chart review was 20% (n = 2/n = 10). Improvements to the identification algorithm, including new EMR visit types, were identified. PDA completion was associated with less decisional conflict and higher perceived Shared decision-making (all P<.03). CONCLUSION: No previous studies have investigated the challenges of implementing a PDA facilitated by the EMR. We identified modifiable system and EMR-related factors that limited program penetration. Our PDA showed decisional quality benefits.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Peña A, Qian Z, Lambrechts S, et al. Evaluation of Implementation Outcomes After Initiation of a Shared Decision-making Program for Men With Prostate Cancer. Urology. 2019. PMID: 31299329. doi:10.1016/j.urology.2019.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。